United States· US:43538-940_b176bc29-53fc-48a1-bf09-ba250f1d13d7
Neo-Synalar
A medicinal product containing neomycin sulfate; fluocinolone acetonide, registered in United States by Eurofarma, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- NEOMYCIN SULFATE; FLUOCINOLONE ACETONIDE
- Manufacturer
- Eurofarma, Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc1143538940601 TUBE in 1 CARTON (43538-940-60) / 60 g in 1 TUBE
- ndc1143538940994 TUBE in 1 CARTON (43538-940-99) / 3 g in 1 TUBE
- ndc1143538-940-60
- ndc1143538-940-99
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Neomycin sulfate; fluocinolone acetonide in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 9 EEA countries. Names it is sold under:
- Bulgaria · Флуцинар N
- Germany · Jellin-Neomycin
- Hungary · Flucinar N
- Italy · Doricum, Localyn
- Lithuania · Flucinar N
- Latvia · Flucinar N
- Poland · Flucinar N
- Portugal · Synalar N
- Romania · Fluocinolon N Atb
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7cd4f389-4696-4eff-863f-4f6e957f6cc6 GET /v1/drugs/7cd4f389-4696-4eff-863f-4f6e957f6cc6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "3.5; .25",
"substance": "NEOMYCIN SULFATE; FLUOCINOLONE ACETONIDE",
"productndc": "43538-940",
"dosage_form": "CREAM",
"dea_schedule": null,
"strength_unit": "mg/g; mg/g",
"application_number": "ANDA060700",
"marketing_category": "ANDA"
}See everything about neomycin sulfate; fluocinolone acetonide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.